D.E. Shaw & Co’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-666,171
| Closed | -$6.68M | – | 3955 |
|
|
2022
Q3 | $6.68M | Hold |
666,171
| – | – | 0.01% | 1200 |
|
|
2022
Q2 | $6.6M | Buy |
666,171
+162,000
| +32% | +$1.6M | 0.01% | 1299 |
|
|
2022
Q1 | $4.97M | Buy |
504,171
+25,502
| +5% | +$251K | ﹤0.01% | 1675 |
|
|
2021
Q4 | $4.67M | Buy |
478,669
+302,988
| +172% | +$2.96M | ﹤0.01% | 1726 |
|
|
2021
Q3 | $1.72M | Buy |
175,681
+54,646
| +45% | +$534K | ﹤0.01% | 2196 |
|
|
2021
Q2 | $1.19M | Buy |
+121,035
| New | +$1.19M | ﹤0.01% | 2399 |
|